文献速递肾小球疾病

C3肾小球病中蛋白尿纵向变化与肾脏结局的关联

Longitudinal change in proteinuria and kidney outcomes in C3 glomerulopathy.
PubMed 文献 · Nephrol Dial Transplant · 2022-01-01

本研究为西班牙多中心回顾性队列研究,纳入85例C3肾小球病患者,采用联合模型分析蛋白尿纵向轨迹与肾衰竭风险的关联。中位随访42个月,25例进展至肾衰竭;蛋白尿倍增使肾衰竭风险增加2.5倍,而蛋白尿较基线下降≥50%与肾衰竭风险降低显著相关(HR 0.79,95%CI 0.56-0.97,P<0.001)。

要点

  • 蛋白尿纵向变化与C3肾小球病肾衰竭风险强烈相关。
  • 蛋白尿倍增对应肾衰竭风险增加2.5倍。
  • 随访中蛋白尿下降≥50%与肾衰竭风险降低独立相关。

核心结论

  • 蛋白尿的纵向变化与C3肾小球病患者的肾衰竭风险强烈相关。
  • 蛋白尿随时间的变化可为临床医生提供肾脏结局的动态预测。

研究设计与样本

  • 西班牙肾小球疾病研究组35个肾内科参与的回顾性、多中心观察性队列研究。
  • 纳入1995年至2020年诊断为C3肾小球病的患者,共85例(70例C3肾小球肾炎,15例致密物沉积病),中位年龄26岁(范围13-41)。
  • 采用线性混合效应模型与Cox模型的联合建模评估重复测量蛋白尿的潜在轨迹及其与肾衰竭风险的关联。

主要发现

  • 中位随访42个月期间,25例患者达到肾衰竭。
  • 蛋白尿的纵向变化与肾衰竭风险强烈相关,蛋白尿水平倍增导致风险增加2.5倍。
  • 随时间蛋白尿下降≥50%与较低的肾衰竭风险显著相关(风险比0.79;95%置信区间0.56-0.97;P<0.001)。
  • 在随访前6个月和12个月内观察到蛋白尿下降≥50%时,该关联同样存在。

临床怎么用

  • 临床中应动态监测C3肾小球病患者的蛋白尿变化,而非仅依赖单次测量。
  • 蛋白尿下降≥50%可作为肾脏结局改善的预测指标,早期(6或12个月内)下降同样有预后意义。

局限性

  • 回顾性观察性设计,可能存在残余混杂。
  • 样本量较小(85例),事件数有限(25例肾衰竭)。
  • 未报告原文中关于其他局限性(如缺失数据、治疗方案变化)的信息。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

INTRODUCTION: The association between a change in proteinuria over time and its impact on kidney prognosis has not been analysed in complement component 3 (C3) glomerulopathy. This study aims to investigate the association between the longitudinal change in proteinuria and the risk of kidney failure. METHODS: This was a retrospective, multicentre observational cohort study in 35 nephrology departments belonging to the Spanish Group for the Study of Glomerular Diseases. Patients diagnosed with C3 glomerulopathy between 1995 and 2020 were enrolled. A joint modelling of linear mixed-effects models was applied to assess the underlying trajectory of a repeatedly measured proteinuria, and a Cox model to evaluate the association of this trajectory with the risk of kidney failure. RESULTS: The study group consisted of 85 patients, 70 C3 glomerulonephritis and 15 dense deposit disease, with a median age of 26 years (range 13-41). During a median follow-up of 42 months, 25 patients reached kidney failure. The longitudinal change in proteinuria showed a strong association with the risk of this outcome, with a doubling of proteinuria levels resulting in a 2.5-fold increase of the risk. A second model showed that a ≥50% proteinuria reduction over time was significantly associated with a lower risk of kidney failure (hazard ratio 0.79; 95% confidence interval 0.56-0.97; P < 0.001). This association was also found when the ≥50% proteinuria reduction was observed within the first 6 and 12 months of follow-up. CONCLUSIONS: The longitudinal change in proteinuria is strongly associated with the risk of kidney failure. The change in proteinuria over time can provide clinicians a dynamic prediction of kidney outcomes.

来源:Nephrol Dial Transplant,查看原文。版权归原作者所有。

引用

  1. Caravaca-Fontán F, Díaz-Encarnación M, Cabello V, et al. Longitudinal change in proteinuria and kidney outcomes in C3 glomerulopathy. Nephrol Dial Transplant. 2022. PMID: 33779754. doi:10.1093/ndt/gfab075

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。